We are live on
!
Find out more
HA
HHLR Advisors Portfolio holdings
AUM
$1.67B
1-Year Est. Return
7.53%
This Fund
S&P 500
This Quarter
Est. Return
+25.13%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$4.74B
AUM Growth
+$934M
(+25%)
Cap. Flow
+$335M
Cap. Flow
% of AUM
7.07%
Top 10 Holdings %
Top 10 Hldgs %
75.66%
Holding
73
New
12
Increased
9
Reduced
24
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$219M |
| 2 |
KE Holdings
BEKE
|
+$138M |
| 3 |
Alibaba
BABA
|
+$69.8M |
| 4 |
Pinduoduo
PDD
|
+$62.1M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$40M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$100M |
| 2 |
Mondelez International
MDLZ
|
+$50M |
| 3 |
JKS
JinkoSolar
JKS
|
+$30.7M |
| 4 |
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
|
+$21.9M |
| 5 |
Gossamer Bio
GOSS
|
+$20.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.12% |
| 2 | Consumer Discretionary | 33.15% |
| 3 | Technology | 12.08% |
| 4 | Real Estate | 6.2% |
| 5 | Materials | 5.03% |
Similar funds
TFS
GC
PA
LCI
JPM
NRI
CPO
JIP
HHLR Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, HHLR Advisors held 73 positions worth $4.74B, up 25% from $3.8B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
HHLR Advisors deployed $335M of net new capital in Q4 2022, opening 12 new positions and adding to 9 existing holdings. Its largest new stake was Freeport-McMoran: 6,274,800 shares worth $238M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Salesforce, an estimated $100M trimmed.
- HHLR Advisors's largest Q4 2022 buy was Freeport-McMoran: 6,274,800 shares worth $238M.
- HHLR Advisors added most to KE Holdings in Q4 2022, an estimated $138M increase.
- HHLR Advisors's biggest Q4 2022 reduction was Salesforce, cutting an estimated $100M.
- HHLR Advisors fully exited Forma Therapeutics Holdings, Inc. Common Stock in Q4 2022, selling an estimated $21.9M.
- HHLR Advisors's ten largest holdings make up 76% of its $4.74B portfolio in Q4 2022.
- HHLR Advisors opened 12 new positions and closed 6 in Q4 2022.
- HHLR Advisors's portfolio value rose 25% quarter-over-quarter to $4.74B.
Based on HHLR Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.